Advertisement
Advertisement

Spotlight Center on HIV Prevention Today

News

Injectables and Implantables Are Next Generation of HIV Prevention

July 27, 2016

On behalf of IFARA, Fred Schaich spoke with Carl Dieffenbach, Ph.D., about the HIV prevention research presented at this year's International AIDS Conference. Results from the HVTN 100 trial in South Africa, which tested a preventive vaccine modified specifically for that country, exceeded expectations, paving the way for a large-scale efficacy trial of the compound that will start this November. The AMP study in Germany, the Americas and Sub-Saharan Africa is testing an infusion of one broadly neutralizing antibody, VRC01, every eight weeks to learn whether this will prevent the acquisition of HIV. If it proves to be 50% effective, the vaccine might be licensed in South Africa, paving the way for more extensive clinical trials. A phase IIa safety study is looking at cabotegravir as an injectable pre-exposure prophylaxis agent. If it proves to be safe, licensing trials for that form of prevention might start within the next year. The next revolution in HIV prevention will be injectable and implantable forms of prophylaxis, Dieffenbach predicted.

Watch the video to learn more:



About the panelist:

  • Carl Dieffenbach, Ph.D., Division of AIDS, U.S. National Institute of Allergy and Infectious Diseases

The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.

Barbara Jungwirth is a freelance writer and translator based in New York.

Follow Barbara on Twitter: @reliabletran.


Copyright © 2016 Remedy Health Media, LLC. All rights reserved.


Related Stories

Really Rapid Review -- AIDS 2016, Durban
This Week in HIV Research: Taking Treatment Four Days a Week Maintains Viral Suppression, and On-Demand PrEP Highly Effective
NIH's Dr. Dieffenbach Shares Final Update From AIDS 2016


This article was provided by TheBodyPRO.com. It is a part of the publication The 21st International AIDS Conference (AIDS 2016).


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.